Why the study?
Despite advances in fetal cardiac and newborn pulse oximetry screening, serious cardiac abnormalities may still be missed.
Design
Review
Authors
Loading...
Supports prenatal screening for safer tertiary delivery in duct-dependent lesions; leaves open prospective outcome validation.
Fetal cardiac ultrasound and newborn pulse oximetry screening are crucial for early detection of congenital heart disease, but clinical evaluation remains necessary for missed lesions.
Menahem et al. (2021) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: